Xiaowei Zheng, MS

MS Zheng was born in Zhejiang (China) on August the 10th, 1982. She has taken the degree in 2009 and and the specialization in oncology in 2012. She worked in Zhejiang Cancer Hospital for ten years and currently serves as clinical pharmacist in Zhejiang Provincial People's Hospital.

She is “young post expert” in Zhejiang Province, member of chemotherapy Committee of Chinese Pharmacological Association, member of National Youth expert Committee on Clinical Application of antineoplastic drugs, member of Clinical antineoplastic Drug Evaluation Branch of China Medical Education Association, Secretary of Oncology Pharmacy Group of Hospital Pharmacy Committee of Zhejiang Pharmaceutical Association.

The main areas of research include: clinical management of antineoplastic drugs and the mechanism of drug resistance on cancer. Hosting one National Natural Science Foundation of China and one Natural Science Foundation of Zhejiang Province. She has published more than 14 articles, authorized 2 invention patents and 5 software copyrights.

Articles Published in the Annals of Translational Medicine

Adverse events of different PD-1 inhibitors in lung cancer patients: a real-world study